Insider Selling: Trupanion (NASDAQ:TRUP) COO Sells 431 Shares

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 431 shares of Trupanion stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $25.35, for a total transaction of $10,925.85. Following the completion of the sale, the chief operating officer owned 32,634 shares of the company’s stock, valued at $827,271.90. This trade represents a 1.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trupanion Stock Up 5.6%

Shares of TRUP traded up $1.38 during mid-day trading on Wednesday, hitting $26.15. 463,321 shares of the company’s stock were exchanged, compared to its average volume of 382,592. The firm has a fifty day moving average of $23.72 and a two-hundred day moving average of $28.17. Trupanion, Inc. has a twelve month low of $21.16 and a twelve month high of $57.00. The stock has a market cap of $1.14 billion, a price-to-earnings ratio of 44.32 and a beta of 1.39. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.25.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The business had revenue of $384.05 million for the quarter, compared to the consensus estimate of $379.77 million. During the same quarter last year, the firm earned ($0.03) EPS. Trupanion’s revenue for the quarter was up 12.3% on a year-over-year basis. On average, sell-side analysts forecast that Trupanion, Inc. will post 0.54 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have recently issued reports on TRUP shares. Stifel Nicolaus set a $28.00 price target on Trupanion in a research note on Friday, June 26th. Cantor Fitzgerald reduced their target price on Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a report on Thursday, April 9th. Bank of America decreased their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $41.50.

Hedge Funds Weigh In On Trupanion

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Kelleher Financial Advisors acquired a new position in Trupanion in the 3rd quarter valued at approximately $74,000. Kemnay Advisory Services Inc. acquired a new stake in shares of Trupanion during the 4th quarter worth approximately $64,000. Parallel Advisors LLC increased its position in shares of Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares during the period. PNC Financial Services Group Inc. raised its stake in shares of Trupanion by 21.7% in the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after purchasing an additional 478 shares in the last quarter. Finally, Advisory Services Network LLC acquired a new position in shares of Trupanion in the third quarter valued at $160,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.